Keros Therapeutics Inc

06/09/2023 | Press release | Distributed by Public on 06/09/2023 04:43

A Modified Activin Receptor Type II Ligand Trap RKER-050 Restored Erythropoiesis in a Mouse Model of Myelofibrosis